Wen Jiang, PhD
Department of CNS - Rad Onc Clinical, Division of Radiation Oncology
About Wen Jiang
Dr. Jiang is currently an Associate Professor with tenure in the Department of Radiation Oncology and a Physician-Scientist in the CNS
section. Dr. Jiang received his PhD in Bioengineering from the University of
Toronto and his MD from Stanford University. He completed his residency
training at MD Anderson Cancer Center in 2018. He subsequently joined UT
Southwestern Medical Center as a tenure-track assistant professor of Radiation
Oncology and a CPRIT Scholar prior to returning to MD Anderson in 2021. Dr. Jiang cares for patients with
primary and secondary CNS tumors. His research focuses on the understanding of
immune suppressive mechanisms within solid tumors and identifying novel
therapeutic strategies to overcome immune escape. Dr. Jiang’s research is
supported by CPRIT, NCI, NINDS, the Department of Defense, the American Cancer Society, and the Susan G.
Komen Foundation.
Read More
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2013 | Stanford University, Stanford, California, US, MD |
| 2008 | University of Toronto, Toronto, CA, Biomedical Engineering, Ph.D |
| 2003 | Carleton University, Ottawa, CA, Electrical Engineering, BS |
Postgraduate Training
| 2014-2018 | Clinical Residency, Radiation Oncology, MD Anderson Cancer Center, Houston, Texas |
| 2013-2014 | Clinical Internship, Internal Medicine, Santa Clara Valley Medical Center, San Jose, California |
| 2009-2013 | Research Fellowship, Tumor Immunology, Stanford School of Medicine, Stanford, California |
| 2008-2009 | Research Fellowship, Tumor Biology, Massachusetts General Hospital, Boston, Massachusetts |
Board Certifications
| 2019 | American Board of Radiology |
Experience & Service
Academic Appointments
Assistant Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - 2023
Assistant Professor, Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX, 2018 - 2021
Other Appointments/Responsibilities
Consultant, Innovent, Houston, TX, 2021 - Present
Institutional Committee Activities
Member, Faculty Recruitment Committee, 2024 - Present
Member, Odyssey Fellowship Committee, 2024 - Present
Member, Breakthrough Cancer GBM Team, 2022 - Present
Member, Brain Tumor Center Executive Committee, 2021 - Present
Member, Radiation Oncology Strategic Initiative (ROSI) ImmunoRT Committee, 2021 - Present
Honors & Awards
| 2024 | Andrew Sabin Family Foundation Fellowship, UT-MD Anderson Cancer Center |
| 2024 | Willie Tichenor Fellowship in Sarcoma Research, UT-MD Anderson Cancer Center |
| 2023 | Faculty Research Excellence Award, UT MD Anderson Cancer Center |
| 2023 | Faculty Scholar Award, UT MD Anderson Cancer Center |
| 2019 | NCI K08 Mentored Clinician-Scientist Career Development Award, NCI |
| 2019 | Circle of Friends Cancer Research Award, UT Southwestern |
| 2018 | A. Lavoy Moore Endowed Clinical Fellow, MD Anderson |
| 2018 | Jeffrey Lee Cousins Fellowship in Lung Cancer Research, MD Anderson |
| 2018 | Rising STARS Award, University of Texas System |
| 2018 | CPRIT Scholar in Cancer Research, CPRIT |
| 2017 | Annual Meeting Travel Award, ASTRO |
| 2017 | Roentgen Resident/Fellow Research Award, RSNA |
| 2017 | Susan Papizan Dolan Fellowship in Breast Oncology, MD Anderson |
| 2017 | ASCO Young Investigator Award, Conquer Cancer Foundation |
| 2016 | Travel Award, RSNA Annual Meeting |
| 2016 | Research Resident Grant, RSNA Annual Meeting |
| 2016 | Workshop on Methods in Clinical Cancer Research, AACR/ASCO - Vail, CO |
| 2016 | Trainee Award - E.D. Montague Research Excellence Award, MD Anderson |
| 2015 | Trainee Award – Gilbert Fletcher Society Award, MD Anderson |
| 2014 | Young Alumni Achievement Award, Carleton University |
| 2011 | Banting Postdoctoral Fellowship Award, Government of Canada |
| 2010 | Scholar Research Fellowship, Stanford Medical |
| 2008 | Graduate Student Award, National Cancer Institute of Canada (NCIC) |
| 2008 | Post-Doctoral Fellowship, Natural Science and Engineering Research Council of Canada |
| 2008 | Paul B. Madsen Award, University of Toronto |
| 2008 | Brain Star National Award, Canadian Institutes of Health Research (CIHR) |
| 2008 | Distinguished Graduate Student Dissertation Award, University of Toronto |
| 2008 | 1st Place: School of Graduate Studies, University of Toronto |
| 2008 | John Leyerle-Canadian Institute for Advanced Research (CIFAR) Award, Canadian Institute for Advanced Research (CIFAR) |
| 2005 | Alexander Graham Bell Canada Scholarship for Doctoral Studies, NSERC |
| 2003 | Ontario Graduate Scholarship for Academic Excellence, Ontario |
| 2003 | Dean’s Honor List, Carleton University |
| 2003 | Senate Medal for Outstanding Academic Achievement, Carleton University |
| 2002 | Dean’s Honor List, Carleton University |
| 2002 | Chipworks Award for Excellence in Electrical Engineering, Carleton University |
| 2001 | Dean’s Honor List, Carleton University |
| 2000 | Dean’s Honor List, Carleton University |
| 1999 | Ontario Scholar, Ontario |
| 1999 | Nortel Networks Scholarship, Nortel Networks |
| 1999 | Ottawa Hydro Top Electrical Engineer Scholarship, Ottawa |
| 1999 | Dean’s Honor List, Carleton University |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Schrank BR, Wang Y, Wu A, Tran N, Lee D, Antony A, Huntoon K, Dong S, Ha J, Ma Y, Grippin AJ, Jeong S, Cheng M, Edwards JL, Gallup TD, Koong AC, Li J, Yun K, Kim BY, Jiang W. A microbial-inspired antibody-toxin conjugate for cancer immunotherapy. Nature Cancer None(None):None. e-Pub 2024. PMID: None.
- Beckham TH, Rooney MK, McAleer MF, Ghia AJ, Tom MC, Perni S, McGovern S, Grosshans D, Chung C, Wang C, De B, Swanson T, Paulino A, Jiang W, Ferguson S, Patel CB, Li J, Yeboa DN. Hypofractionated radiotherapy for glioblastoma: A large institutional retrospective assessment of 2 approaches. Neurooncol Pract 11(3):266-274, 2024. e-Pub 2024. PMID: 38737610.
- Sun L, Niu H, Wu Y, Dong S, Li X, Kim BYS, Liu C, Ma Y, Jiang W, Yuan Y. Bio-integrated scaffold facilitates large bone regeneration dominated by endochondral ossification. Bioact Mater 35(None):208-227, 2024. e-Pub 2024. PMID: 38327823.
- Lee D, Huntoon K, Wang Y, Kang M, Lu Y, Jeong SD, Link TM, Gallup TD, Qie Y, Li X, Dong S, Schrank BR, Grippin AJ, Antony A, Ha J, Chang M, An Y, Wang L, Jiang D, Li J, Koong AC, Tainer JA, Jiang W, Kim BYS. Synthetic cationic helical polypeptides for the stimulation of antitumour innate immune pathways in antigen-presenting cells. Nat Biomed Eng 8(5):593-610, 2024. e-Pub 2024. PMID: 38641710.
- Bian X, Yang L, Jiang D, Grippin AJ, Ma Y, Wu S, Wu L, Wang X, Tang Z, Tang K, Pan W, Dong S, Kim BYS, Jiang W, Yang Z, Li C. Regulation of cerebral blood flow boosts precise brain targeting of vinpocetine-derived ionizable-lipidoid nanoparticles. Nat Commun 15(1):3987, 2024. e-Pub 2024. PMID: 38734698.
- Chang M, Wang M, Liu B, Zhong W, Jana D, Wang Y, Dong S, Antony A, Li C, Liu Y, Zhao Z, Lin J, Jiang W, Zhao Y. A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy. ACS Nano 18(11):8143-8156, 2024. e-Pub 2024. PMID: 38436248.
- Li X, Huntoon K, Wang Y, Lee D, Dong S, Antony A, Walkey C, Kim BYS, Jiang W. Radiation Synergizes with IL-2/IL-15 Stimulation to Enhance Innate Immune Activation and Antitumor Immunity. Mol Cancer Ther 23(3):330-342, 2024. e-Pub 2023. PMID: 37956421.
- Wang Y, Deng W, Lee D, Yan L, Lu Y, Dong S, Huntoon K, Antony A, Li X, Ye R, Zhao Y, Zhao F, Schrank BR, Ha J, Kang M, Yang M, Gong P, Lorenzi PL, Tan L, Gallup TD, Tang SK, Yang Z, Li J, Sanford NN, Wang H, Kim BYS, Jiang W. Age-associated disparity in phagocytic clearance affects the efficacy of cancer nanotherapeutics. Nat Nanotechnol 19(2):255-263, 2024. e-Pub 2023. PMID: 37723279.
- Zhang J, Rima XY, Wang X, Nguyen LTH, Huntoon K, Ma Y, Palacio PL, Nguyen KT, Albert K, Duong-Thi MD, Walters N, Kwak KJ, Yoon MJ, Li H, Doon-Ralls J, Hisey CL, Lee D, Wang Y, Ha J, Scherler K, Fallen S, Lee I, Palmer AF, Jiang W, Magaña SM, Wang K, Kim BYS, Lee LJ, Reátegui E. Engineering a tunable micropattern-array assay to sort single extracellular vesicles and particles to detect RNA and protein in situ. J Extracell Vesicles 12(11):e12369, 2023. PMID: 37908159.
- Chiang CL, Ma Y, Hou YC, Pan J, Chen SY, Chien MH, Zhang ZX, Hsu WH, Wang X, Zhang J, Li H, Sun L, Fallen S, Lee I, Chen XY, Chu YS, Zhang C, Cheng TS, Jiang W, Kim BYS, Reategui E, Lee R, Yuan Y, Liu HC, Wang K, Hsiao M, Huang CF, Shan YS, Lee AS, James Lee L. Dual targeted extracellular vesicles regulate oncogenic genes in advanced pancreatic cancer. Nat Commun 14(1):6692, 2023. e-Pub 2023. PMID: 37872156.
- Dong S, Liu X, Bi Y, Wang Y, Antony A, Lee D, Huntoon K, Jeong S, Ma Y, Li X, Deng W, Schrank BR, Grippin AJ, Ha J, Kang M, Chang M, Zhao Y, Sun R, Sun X, Yang J, Chen J, Tang SK, Lee LJ, Lee AS, Teng L, Wang S, Teng L, Kim BYS, Yang Z, Jiang W. Adaptive design of mRNA-loaded extracellular vesicles for targeted immunotherapy of cancer. Nat Commun 14(1):6610, 2023. e-Pub 2023. PMID: 37857647.
- You Y, Tian Y, Yang Z, Shi J, Kwak KJ, Tong Y, Estania AP, Cao J, Hsu WH, Liu Y, Chiang CL, Schrank BR, Huntoon K, Lee D, Li Z, Zhao Y, Zhang H, Gallup TD, Ha J, Dong S, Li X, Wang Y, Lu WJ, Bahrani E, Lee LJ, Teng L, Jiang W, Lan F, Kim BYS, Lee AS. Intradermally delivered mRNA-encapsulating extracellular vesicles for collagen-replacement therapy. Nat Biomed Eng 7(7):887-900, 2023. e-Pub 2023. PMID: 36635419.
- Huntoon K, Anderson SK, Ballman KV, Twohy E, Dooley K, Jiang W, An Y, Li J, von Roemeling C, Qie Y, Ross OA, Cerhan JH, Whitton AC, Greenspoon JN, Parney IF, Ashman JB, Bahary JP, Hadjipanayis C, Urbanic JJ, Farace E, Khuntia D, Laack NN, Brown PD, Roberge D, Kim BYS. Association of Circulating Markers with Cognitive Decline After Radiation Therapy for Brain Metastasis. Neuro Oncol 25(6):1123-1131, 2023. e-Pub 2022. PMID: 36472389.
- Lu Y, Huntoon K, Lee D, Wang Y, Ha J, Qie Y, Li X, Schrank BR, Dong S, Gallup TD, Kang M, Zhao H, An Y, Yang Z, Li J, Kim BYS, Jiang W. Immunological conversion of solid tumours using a bispecific nanobioconjugate for cancer immunotherapy. Nat Nanotechnol 17(12):1332-1341, 2022. e-Pub 2022. PMID: 36357792.
- Huang X, Liu Q, Zhong G, Peng Y, Liu Y, Liang L, Hong H, Feng W, Yang S, Zhang Y, Xian S, Li Z, Zhou Y, Zhang Z, Jiang W, Liang J, Liu ZG. Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial. J Exp Clin Cancer Res 41(1):300, 2022. e-Pub 2022. PMID: 36224603.
- Li X, Khorsandi S, Wang Y, Santelli J, Huntoon K, Nguyen N, Yang M, Lee D, Lu Y, Gao R, Kim BYS, de Gracia Lux C, Mattrey RF, Jiang W, Lux J. Cancer immunotherapy based on image-guided STING activation by nucleotide nanocomplex-decorated ultrasound microbubbles. Nat Nanotechnol 17(8):891-899, 2022. e-Pub 2022. PMID: 35637356.
- Li J, Xue C, Wang H, Dong S, Yang Z, Cao Y, Zhao B, Cheng B, Xie X, Mo X, Jiang W, Yuan H, Pan J. Hybrid Nanofibrous Composites with Anisotropic Mechanics and Architecture for Tendon/Ligament Repair and Regeneration. Small 18(27):e2201147, 2022. e-Pub 2022. PMID: 35686342.
- George J, Chen Y, Abdelfattah N, Yamamoto K, Gallup TD, Adamson SI, Rybinski B, Srivastava A, Kumar P, Lee MG, Baskin DS, Jiang W, Choi JM, Flavahan W, Chuang JH, Kim BYS, Xu J, Jung SY, Yun K. Cancer stem cells, not bulk tumor cells, determine mechanisms of resistance to SMO inhibitors. Cancer Research Communications 2(6):402-416, 2022. PMID: None.
- Hein DM, Deng W, Bleile M, Kazmi SA, Rhead B, De La Vega FM, Jones AL, Kainthla R, Jiang W, Cantarel B, Sanford NN. Racial and Ethnic Differences in Genomic Profiling of Early-Onset Colorectal Cancer. J Natl Cancer Inst 114(5):775-778, 2022. e-Pub 2022. PMID: 35134211.
- Liu J, Wang Y, Tian Z, Lin Y, Li H, Zhu Z, Liu Q, Su S, Zeng Y, Jia W, Yang Y, Xu S, Yao H, Jiang W, Song E. Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer. Nat Commun 13(1):3011, 2022. e-Pub 2022. PMID: 35641481.
- Dong S, Bi Y, Sun X, Zhao Y, Sun R, Hao F, Sun Y, Wang Y, Li X, Deng W, Liu X, Ha J, Teng L, Gong P, Xie J, Kim BYS, Yang Z, Jiang W, Teng L. Dual-Loaded Liposomes Tagged with Hyaluronic Acid Have Synergistic Effects in Triple-Negative Breast Cancer. Small 18(16):e2107690, 2022. e-Pub 2022. PMID: 35277914.
- Abdelfattah N, Kumar P, Wang C, Leu JS, Flynn WF, Gao R, Baskin DS, Pichumani K, Ijare OB, Wood SL, Powell SZ, Haviland DL, Parker Kerrigan BC, Lang FF, Prabhu SS, Huntoon KM, Jiang W, Kim BYS, George J, Yun K. Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target. Nat Commun 13(1):767, 2022. e-Pub 2022. PMID: 35140215.
- Sun Z, Deng G, Peng X, Xu X, Liu L, Peng J, Ma Y, Zhang P, Wen A, Wang Y, Yang Z, Gong P, Jiang W, Cai L. Intelligent photothermal dendritic cells restart the cancer immunity cycle through enhanced immunogenic cell death. Biomaterials 279(None):121228, 2021. e-Pub 2021. PMID: 34717198.
- Yu S, Wei S, Savani M, Lin X, Du K, Mender I, Siteni S, Vasilopoulos T, Reitman ZJ, Ku Y, Wu D, Liu H, Tian M, Chen Y, Labrie M, Charbonneau CM, Sugarman E, Bowie M, Hariharan S, Waitkus M, Jiang W, McLendon RE, Pan E, Khasraw M, Walsh KM, Lu Y, Herlyn M, Mills G, Herbig U, Wei Z, Keir ST, Flaherty K, Liu L, Wu K, Shay JW, Abdullah K, Zhang G, Ashley DM. A Modified Nucleoside 6-thio-2'-deoxyguanosine Exhibits Anti-tumor Activity in Gliomas. Clin Cancer Res 27(24):6800-6814, 2021. e-Pub 2021. PMID: 34593527.
- Ma Y, Yang Z, Huntoon K, Jiang W, Kim BYS. Advanced immunotherapy approaches for glioblastoma. Advanced Therapeutics 4(8), 2021. PMID: None.
- Zhang N, Yin R, Zhou P, Liu X, Fan P, Qian L, Dong L, Zhang C, Zheng X, Deng S, Kuai J, Liu Z, Jiang W, Wang X, Wu D, Huang Y. DLL1 orchestrates CD8+ T cells to induce long-term vascular normalization and tumor regression. Proc Natl Acad Sci U S A 118(22), 2021. PMID: 34035167.
- Liu Y, Yang Z, Wang L, Sun L, Kim BYS, Jiang W, Yuan Y, Liu C. Spatiotemporal Immunomodulation Using Biomimetic Scaffold Promotes Endochondral Ossification-Mediated Bone Healing. Adv Sci (Weinh) 8(11):e2100143, 2021. e-Pub 2021. PMID: 34105266.
- Sun X, Yu K, Zhou Y, Dong S, Hu W, Sun Y, Li Y, Xie J, Lee RJ, Sun F, Ma Y, Wang S, Kim BYS, Wang Y, Yang Z, Jiang W, Li Y, Teng L. Self-Assembled pH-Sensitive Polymeric Nanoparticles for the Inflammation-Targeted Delivery of Cu/Zn-Superoxide Dismutase. ACS Appl Mater Interfaces 13(15):18152-18164, 2021. e-Pub 2021. PMID: 33764751.
- Huang C, Chen L, Savage SR, Eguez RV, Dou Y, Li Y, da Veiga Leprevost F, Jaehnig EJ, Lei JT, Wen B, Schnaubelt M, Krug K, Song X, Cieslik M, Chang HY, Wyczalkowski MA, Li K, Colaprico A, Li QK, Clark DJ, Hu Y, Cao L, Pan J, Wang Y, Cho KC, Shi Z, Liao Y, Jiang W, Anurag M, Ji J, Yoo S, Zhou DC, Liang WW, Wendl M, Vats P, Carr SA, Mani DR, Zhang Z, Qian J, Chen XS, Pico AR, Wang P, Chinnaiyan AM, Ketchum KA, Kinsinger CR, Robles AI, An E, Hiltke T, Mesri M, Thiagarajan M, Weaver AM, Sikora AG, Lubinski J, Wierzbicka M, Wiznerowicz M, Satpathy S, Gillette MA, Miles G, Ellis MJ, Omenn GS, Rodriguez H, Boja ES, Dhanasekaran SM, Ding L, Nesvizhskii AI, El-Naggar AK, Chan DW, Zhang H, Zhang B, Analysis Consortium CPT. Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma. Cancer Cell 39(3):361-379.e16, 2021. e-Pub 2021. PMID: 33417831.
- Xie S, Shalaby-Rana E, Hester A, Honeycutt J, Fu CL, Boyett D, Jiang W, Hsieh MH. Macroscopic and microscopic imaging modalities for diagnosis and monitoring of urogenital schistosomiasis. Adv Parasitol 112:51-76, 2021. e-Pub 2021. PMID: 34024359.
- Westover KD, Mendel JT, Dan T, Kumar K, Gao A, Pulipparacharuv S, Iyengar P, Nedzi L, Hannan R, Anderson J, Choe KS, Jiang W, Abdulrahman R, Rahimi A, Folkert M, Laine A, Presley C, Cullum CM, Choy H, Ahn C, Timmerman R. Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer. Neuro Oncol 22(12):1831-1839, 2020. PMID: 32347302.
- Deng W, Wang Y, Liu X, Liu J, Wang L, Yang Z, Yang M, An Y, Tang C, Sanford NN, Kim BYS, Jiang W. Assessment of Trends in Second Primary Cancers in Patients With Metastatic Melanoma From 2005 to 2016. JAMA Netw Open 3(12):e2028627, 2020. e-Pub 2020. PMID: 33295975.
- Wei W, Jiang H, Chen W, Zhou Y, Guo S, Zhong G, Zhou H, Wang S, Zhang H, Jiang W, Liu ZG. How should we implement radiotherapy for cancer patients in China during the endemic period of COVID-19?. Radiother Oncol 147:100-102, 2020. e-Pub 2020. PMID: 32259751.
- Wang L, Dong S, Liu Y, Ma Y, Zhang J, Yang Z, Jiang W, Yuan Y. Fabrication of Injectable, Porous Hyaluronic Acid Hydrogel Based on an In-Situ Bubble-Forming Hydrogel Entrapment Process. Polymers (Basel) 12(5), 2020. e-Pub 2020. PMID: 32429363.
- Wei W, Zhou J, Zhang Q, Liao DH, Liu QD, Zhong BL, Liang ZB, Zhang YC, Jiang R, Liu GY, Xu CY, Li Zhou H, Zhu SY, Yang N, Jiang W, Liu ZG. Postoperative intensity-modulated radiation therapy reduces local recurrence and improves overall survival in III-N2 non-small-cell lung cancer: A single-center, retrospective study. Cancer Med 9(8):2820-2832, 2020. e-Pub 2020. PMID: 32100444.
- Li Q, Wang Y, Jia W, Deng H, Li G, Deng W, Chen J, Kim BYS, Jiang W, Liu Q, Liu J. Low-Dose Anti-Angiogenic Therapy Sensitizes Breast Cancer to PD-1 Blockade. Clin Cancer Res 26(7):1712-1724, 2020. e-Pub 2019. PMID: 31848190.
- von Roemeling CA, Wang Y, Qie Y, Yuan H, Zhao H, Liu X, Yang Z, Yang M, Deng W, Bruno KA, Chan CK, Lee AS, Rosenfeld SS, Yun K, Johnson AJ, Mitchell DA, Jiang W, Kim BYS. Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nat Commun 11(1):1508, 2020. e-Pub 2020. PMID: 32198351.
- Zheng X, Zhang N, Qian L, Wang X, Fan P, Kuai J, Lin S, Liu C, Jiang W, Qin S, Chen H, Huang Y. CTLA4 blockade promotes vessel normalization in breast tumors via the accumulation of eosinophils. Int J Cancer 146(6):1730-1740, 2020. e-Pub 2019. PMID: 31840816.
- Yang Z, Shi J, Xie J, Wang Y, Sun J, Liu T, Zhao Y, Zhao X, Wang X, Ma Y, Malkoc V, Chiang C, Deng W, Chen Y, Fu Y, Kwak KJ, Fan Y, Kang C, Yin C, Rhee J, Bertani P, Otero J, Lu W, Yun K, Lee AS, Jiang W, Teng L, Kim BYS, Lee LJ. Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation. Nat Biomed Eng 4(1):69-83, 2020. e-Pub 2019. PMID: 31844155.
- Li N, Wang Y, Neri S, Zhen Y, Fong LWR, Qiao Y, Li X, Chen Z, Stephan C, Deng W, Ye R, Jiang W, Zhang S, Yu Y, Hung MC, Chen J, Lin SH. Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling. Nat Commun 10(1):4363, 2019. e-Pub 2019. PMID: 31554794.
- Chen Y, Liu X, Yuan H, Yang Z, von Roemeling CA, Qie Y, Zhao H, Wang Y, Jiang W, Kim BYS. Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery. Adv Sci (Weinh) 6(5):1802070, 2019. e-Pub 2019. PMID: 30886813.
- Liu Y, Song Y, Lin D, Lei L, Mei Y, Jin Z, Gong H, Zhu Y, Hu B, Zhang Y, Zhao L, Teo HY, Qiu J, Jiang W, Dong C, Wu D, Huang Y, Liu H. NCR- group 3 innate lymphoid cells orchestrate IL-23/IL-17 axis to promote hepatocellular carcinoma development. EBioMedicine 41:333-344, 2019. e-Pub 2019. PMID: 30827928.
- An Y, Jiang W, Andraos TY, Reddy JP, Yehia ZA, Lloyd S, Duvic M, D'Souza NM, Milgrom SA, Pinnix CC, Oki Y, Smith GL, Wilson LD, Dabaja BS. Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides. Radiother Oncol 131:88-92, 2019. e-Pub 2018. PMID: 30773193.
- Wang Y, Li N, Jiang W, Deng W, Ye R, Xu C, Qiao Y, Sharma A, Zhang M, Hung MC, Lin SH. Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non-Small Cell Lung Cancer. Clin Cancer Res 24(22):5744-5756, 2018. e-Pub 2018. PMID: 30068711.
- Zhang Z, Yang J, Ho A, Jiang W, Logan J, Wang X, Brown PD, McGovern SL, Guha-Thakurta N, Ferguson SD, Fave X, Zhang L, Mackin D, Court LE, Li J. A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images. Eur Radiol 28(6):2255-2263, 2018. e-Pub 2017. PMID: 29178031.
- Zheng X, Fang Z, Liu X, Deng S, Zhou P, Wang X, Zhang C, Yin R, Hu H, Chen X, Han Y, Zhao Y, Lin SH, Qin S, Wang X, Kim BY, Zhou P, Jiang W, Wu Q, Huang Y. Increased vessel perfusion predicts the efficacy of immune checkpoint blockade. J Clin Invest 128(5):2104-2115, 2018. e-Pub 2018. PMID: 29664018.
- Wang Y, Gudikote J, Giri U, Yan J, Deng W, Ye R, Jiang W, Li N, Hobbs BP, Wang J, Swisher SG, Fujimoto J, Wistuba II, Komaki R, Heymach JV, Lin SH. RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non-small Cell Lung Cancer. Clin Cancer Res 24(2):341-350, 2018. e-Pub 2017. PMID: 29030353.
- Lu J, Liu X, Liao YP, Salazar F, Sun B, Jiang W, Chang CH, Jiang J, Wang X, Wu AM, Meng H, Nel AE. Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression. Nat Commun 8(1):1811, 2017. e-Pub 2017. PMID: 29180759.
- Sperduto PW, Jiang W, Brown PD, Braunstein S, Sneed P, Wattson DA, Shih HA, Bangdiwala A, Shanley R, Lockney NA, Beal K, Lou E, Amatruda T, Sperduto WA, Kirkpatrick JP, Yeh N, Gaspar LE, Molitoris JK, Masucci L, Roberge D, Yu J, Chiang V, Mehta M. Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA). Int J Radiat Oncol Biol Phys 99(4):812-816, 2017. PMID: 29063850.
- Chow KH, Park HJ, George J, Yamamoto K, Gallup AD, Graber JH, Chen Y, Jiang W, Steindler DA, Neilson EG, Kim BYS, Yun K. S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma. Cancer Res 77(19):5360-5373, 2017. e-Pub 2017. PMID: 28807938.
- An Y, Jiang W, Kim BYS, Qian JM, Tang C, Fang P, Logan J, D'Souza NM, Haydu LE, Wang XA, Hess KR, Kluger H, Glitza IC, Mahajan A, Welsh JW, Lin SH, Yu JB, Davies MA, Hwu P, Sulman EP, Brown PD, Chiang VLS, Li J. Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control. Radiother Oncol 125(1):80-88, 2017. e-Pub 2017. PMID: 28916225.
- Sperduto PW, Jiang W, Brown PD, Braunstein S, Sneed P, Wattson DA, Shih HA, Bangdiwala A, Shanley R, Lockney NA, Beal K, Lou E, Amatruda T, Sperduto WA, Kirkpatrick JP, Yeh N, Gaspar LE, Molitoris JK, Masucci L, Roberge D, Yu J, Chiang V, Mehta M. The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases. Int J Radiat Oncol Biol Phys 98(5):1069-1077, 2017. e-Pub 2017. PMID: 28721890.
- Yuan H, Jiang W, von Roemeling CA, Qie Y, Liu X, Chen Y, Wang Y, Wharen RE, Yun K, Bu G, Knutson KL, Kim BYS. Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy. Nat Nanotechnol 12(8):763-769, 2017. e-Pub 2017. PMID: 28459470.
- Fang P, Jiang W, Allen P, Glitza I, Guha N, Hwu P, Ghia A, Phan J, Mahajan A, Tawbi H, Li J. Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma. J Neurooncol 133(3):595-602, 2017. e-Pub 2017. PMID: 28500560.
- Jiang W, Yuan H, Chan CK, von Roemeling CA, Yan Z, Weissman IL, Kim BYS. Lessons from immuno-oncology: a new era for cancer nanomedicine?. Nat Rev Drug Discov 16(6):369-370, 2017. e-Pub 2017. PMID: 28303024.
- Jiang W, von Roemeling C, Qie Y, Chen Y, Liu X, Chen J, Kim BYS. Designing nanomedicine for immuno-oncology. Nature Biomedical Engineering 1(None):0029, 2017. PMID: None.
- Abou Yehia Z, Mikhaeel GN, Smith G, Pinnix CC, Milgrom SA, Tang C, Jiang W, Fanale MA, Oki Y, Shank JH, Horace T, Reddy J, Akhtari M, Gunther JR, Suki T, Allen PK, Turner S, Mawlawi O, Dabaja BS. Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?. Int J Radiat Oncol Biol Phys 96(5):951-958, 2016. e-Pub 2016. PMID: 27742539.
- Jiang W, Liu J, Gullane PJ, Gentili F, Wharen RE, Kim BYS, DeMonte F. Non-contiguous meningeal metastases of olfactory neuroblastoma. J Neurooncol 126(1):201-203, 2016. e-Pub 2015. PMID: 26376653.
- Jiang W, Chamberlain PD, Garden AS, Kim BYS, Ma D, Bell D. Prognostic value of p16 expression in Epstein‐Barr virus–positive nasopharyngeal carcinomas. Head & Neck 38, (S1), E1459-E1466(None):None, 2016. PMID: 26560893.
- Jiang W, Huang Y, An Y, Kim BY. Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles. ACS Nano 9(9):8689-96, 2015. e-Pub 2015. PMID: 26212564.
- Liu J, Jiang W, Mao K, An Y, Su F, Kim BY, Liu Q, Jacobs LK. Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis. Breast Cancer Res Treat 150(2):439-45, 2015. e-Pub 2015. PMID: 25764167.
- Tang C, Chan C, Jiang W, Murphy JD, von Eyben R, Colevas AD, Pinto H, Lee-Enriquez N, Kong C, Le QT. Concurrent cetuximab versus platinum-based chemoradiation for the definitive treatment of locoregionally advanced head and neck cancer. Head Neck 37(3):386-92, 2015. e-Pub 2014. PMID: 24431011.
- Kim BYS, Jiang W, Beiko J, Prabhu SS, DeMonte F, Gilbert MR, Sawaya R, Aldape KD, Cahill DP, McCutcheon IE. Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing. J Neurooncol 118(2):405-412, 2014. e-Pub 2014. PMID: 24777756.
- Tang C, Komakula S, Chan C, Murphy JD, Jiang W, Kong C, Lee-Enriquez N, Jensen KC, Fischbein NJ, Le QT. Radiologic assessment of retropharyngeal node involvement in oropharyngeal carcinomas stratified by HPV status. Radiother Oncol 109(2):293-6, 2013. e-Pub 2013. PMID: 24103114.
- Chan CK, Lindau P, Jiang W, Chen JY, Zhang LF, Chen CC, Seita J, Sahoo D, Kim JB, Lee A, Park S, Nag D, Gong Y, Kulkarni S, Luppen CA, Theologis AA, Wan DC, DeBoer A, Seo EY, Vincent-Tompkins JD, Loh K, Walmsley GG, Kraft DL, Wu JC, Longaker MT, Weissman IL. Clonal precursor of bone, cartilage, and hematopoietic niche stromal cells. Proc Natl Acad Sci U S A 110(31):12643-8, 2013. e-Pub 2013. PMID: 23858471.
- Wong C, Stylianopoulos T, Cui J, Martin J, Chauhan VP, Jiang W, Popovic Z, Jain RK, Bawendi MG, Fukumura D. Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Natl Acad Sci U S A 108(6):2426-31, 2011. e-Pub 2011. PMID: 21245339.
- Liu W, Greytak AB, Lee J, Wong CR, Park J, Marshall LF, Jiang W, Curtin PN, Ting AY, Nocera DG, Fukumura D, Jain RK, Bawendi MG. Compact biocompatible quantum dots via RAFT-mediated synthesis of imidazole-based random copolymer ligand. J Am Chem Soc 132(2):472-83, 2010. PMID: 20025223.
- Kim BY, Jiang W, Oreopoulos J, Yip CM, Rutka JT, Chan WC. Biodegradable quantum dot nanocomposites enable live cell labeling and imaging of cytoplasmic targets. Nano Lett 8(11):3887-92, 2008. e-Pub 2008. PMID: 18816147.
- Jiang W, Kim BY, Rutka JT, Chan WC. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 3(3):145-50, 2008. e-Pub 2008. PMID: 18654486.
- Gryczynski I, Malicka J, Jiang W, Fischer H, Chan WC, Gryczynski Z, Grudzinski W, Lakowicz JR. Surface-plasmon-coupled emission of quantum dots. J Phys Chem B 109(3):1088-93, 2005. PMID: 16851064.
Invited Articles
- Leong HS, Butler KS, Brinker CJ, Azzawi M, Conlan S, Dufés C, Owen A, Rannard S, Scott C, Chen C, Dobrovolskaia MA, Kozlov SV, Prina-Mello A, Schmid R, Wick P, Caputo F, Boisseau P, Crist RM, McNeil SE, Fadeel B, Tran L, Hansen SF, Hartmann NB, Clausen LPW, Skjolding LM, Baun A, Ågerstrand M, Gu Z, Lamprou DA, Hoskins C, Huang L, Song W, Cao H, Liu X, Jandt KD, Jiang W, Kim BYS, Wheeler KE, Chetwynd AJ, Lynch I, Moghimi SM, Nel A, Xia T, Weiss PS, Sarmento B, das Neves J, Santos HA, Santos L, Mitragotri S, Little S, Peer D, Amiji MM, Alonso MJ, Petri-Fink A, Balog S, Lee A, Drasler B, Rothen-Rutishauser B, Wilhelm S, Acar H, Harrison RG, Mao C, Mukherjee P, Ramesh R, McNally LR, Busatto S, Wolfram J, Bergese P, Ferrari M, Fang RH, Zhang L, Zheng J, Peng C, Du B, Yu M, Charron DM, Zheng G, Pastore C. On the issue of transparency and reproducibility in nanomedicine. Nat Nanotechnol 14(7):629-635, 2019. PMID: 31270452.
Other Articles
- Zhang H, Grippin A, Sun M, Ma Y, Kim BYS, Teng L, Jiang W, Yang Z New avenues for cancer immunotherapy: Cell-mediated drug delivery systems. J Control Release 375(None):712-732, 2024. PMID: 39326499.
- Wang Y, Xiao Z, Wang Z, Lee D, Ma Y, Wilhelm S, Wang H, Kim BY, Jiang W Multi-omics approaches to decipher the biological-nanoparticle multiverse. Nature Rev Bioengineering None(None):None. PMID: None.
- He Y, Wang Y, Wang L, Jiang W, Wilhelm S Understanding nanoparticle-liver interactions in nanomedicine. Expert Opin Drug Deliv 21(6):829-843, 2024. PMID: 38946471.
- Huntoon K, Lee D, Dong S, Antony A, Kim BYS, Jiang W Targeting phagocytosis to enhance antitumor immunity. Trends Cancer 9(8):650-665, 2023. PMID: 37150626.
- Lee D, Huntoon K, Lux J, Kim BYS, Jiang W Engineering nanomaterial physical characteristics for cancer immunotherapy. Nature Reviews Bioengineering 1(None):499-517, 2023. PMID: None.
- Lee D, Huntoon K, Wang Y, Jiang W, Kim BYS Harnessing Innate Immunity Using Biomaterials for Cancer Immunotherapy. Adv Mater 33(27):e2007576, 2021. PMID: 34050699.
- Jiang W, Wang Y, Wargo JA, Lang FF, Kim BYS Considerations for designing preclinical cancer immune nanomedicine studies. Nat Nanotechnol 16(1):6-15, 2021. PMID: 33349682.
- Liu M, Wu K, Lin J, Xie Q, Liu Y, Huang Y, Zeng J, Yang Z, Wang Y, Dong S, Deng W, Yang M, Wu S, Jiang W, Li X Emerging Biological Functions of IL-17A: A New Target in Chronic Obstructive Pulmonary Disease?. Front Pharmacol 12(None):695957, 2021. PMID: 34305606.
- Gong P, Wang Y, Zhang P, Yang Z, Deng W, Sun Z, Yang M, Li X, Ma G, Deng G, Dong S, Cai L, Jiang W Immunocyte Membrane-Coated Nanoparticles for Cancer Immunotherapy. Cancers (Basel) 13(1):None, 2020. PMID: 33396603.
- Ziu M, Kim BYS, Jiang W, Ryken T, Olson JJ The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update. J Neurooncol 150(2):215-267, 2020. PMID: 33215344.
- Hong WX, Haebe S, Lee AS, Westphalen CB, Norton JA, Jiang W, Levy R Intratumoral Immunotherapy for Early-stage Solid Tumors. Clin Cancer Res 26(13):3091-3099, 2020. PMID: 32071116.
- Ma Y, Dong S, Li X, Kim BYS, Yang Z, Jiang W Extracellular Vesicles: An Emerging Nanoplatform for Cancer Therapy. Front Oncol 10:606906, 2020. PMID: 33628730.
- Feng M, Jiang W, Kim BYS, Zhang CC, Fu YX, Weissman IL Phagocytosis checkpoints as new targets for cancer immunotherapy. Nat Rev Cancer 19(10):568-586, 2019. PMID: 31462760.
- Liu Z, Wang Y, Huang Y, Kim BYS, Shan H, Wu D, Jiang W Tumor Vasculatures: A New Target for Cancer Immunotherapy. Trends Pharmacol Sci 40(9):613-623, 2019. PMID: 31331639.
- Wang Y, Liu ZG, Yuan H, Deng W, Li J, Huang Y, Kim BYS, Story MD, Jiang W The Reciprocity between Radiotherapy and Cancer Immunotherapy. Clin Cancer Res 25(6):1709-1717, 2019. PMID: 30413527.
- Liu Z, Jiang W, Nam J, Moon JJ, Kim BYS Immunomodulating Nanomedicine for Cancer Therapy. Nano Lett 18(11):6655-6659, 2018. PMID: 30185039.
- Huang Y, Kim BYS, Chan CK, Hahn SM, Weissman IL, Jiang W Improving immune-vascular crosstalk for cancer immunotherapy. Nat Rev Immunol 18(3):195-203, 2018. PMID: 29332937.
- Wang Y, Deng W, Li N, Neri S, Sharma A, Jiang W, Lin SH Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions. Front Pharmacol 9:185, 2018. PMID: 29556198.
- von Roemeling C, Jiang W, Chan CK, Weissman IL, Kim BYS Breaking Down the Barriers to Precision Cancer Nanomedicine. Trends Biotechnol 35(2):159-171, 2017. PMID: 27492049.
- Jiang W, Chan CK, Weissman IL, Kim BYS, Hahn SM Immune Priming of the Tumor Microenvironment by Radiation. Trends Cancer 2(11):638-645, 2016. PMID: 28741502.
- D'Souza NM, Fang P, Logan J, Yang J, Jiang W, Li J Combining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System Malignancies. Front Oncol 6:212, 2016. PMID: 27774435.
- Jiang W, Kim BY, Rutka JT, Chan WC Advances and challenges of nanotechnology-based drug delivery systems. Expert Opin Drug Deliv 4(6):621-33, 2007. PMID: 17970665.
- Jiang W, Papa E, Fischer H, Mardyani S, Chan WC Semiconductor quantum dots as contrast agents for whole animal imaging. Trends Biotechnol 22(12):607-9, 2004. PMID: 15542145.
Editorials
- Wang Y, Schrank B, Jiang W, Kim BY. Learning what keeps nanomedicines in tumours. Nature Biomedical Engineering None(None):None. PMID: None.
- Ha J, Grippin AJ, Kim BYS, Jiang W. Striking the Balance with a PD-L1×4-1BB Bispecific Antibody. Cancer Res 84(10):1546-1547, 2024. PMID: 38745496.
- Huntoon K, Jiang W, Kim BY. Waking immune-resistant tumors with neddylation. J Clin Invest 133(4):None, 2023. PMID: 36787255.
- Tang C, Jiang W, Yap TA. Efficacy and Toxic Effects of Cancer Immunotherapy Combinations-A Double-edged Sword. JAMA Oncol 4(8):1116-1117, 2018. PMID: 29327039.
- Jiang W. A tale of two disciplines. Nat Nanotechnol 11(8):732, 2016. PMID: 27485586.
Book Chapters
- Yoon JW, Jiang W, Huang YH, Rutka JT, Kim BYS. Perspectives of nanotechnology in the management of gliomas. In: Chernov MF, Muragaki Y, Kesari S, McCutcheon IE. Progress in Neurological Surgery. 1st ed. None. Karger, 2015.
- Jiang W, Singhal A, Fischer H, Mardyani S, Chan WCW. Engineering biocompatible quantum dots for real-time, ultrasensitive biological imaging and detection. In: Therapeutic Micro/Nanotechnology, Bhatia S, and Desai T, eds. None. Kluwer Publishing, 2006.
- Mardyani S, Jiang W, Lai J, Zhang J, Chan WCW. Bioinspired approaches to build nanoscale devices. In: Biological Nanostructures and Applications of Nanostructures in Biology, Stoscio M, and Dutta M, eds. None. Kluwer Publishing, 2004.
Grant & Contract Support
| Title: | Engineering a Targeted, Acoustically Responsive Image-Guided GBM Immunotherapy |
| Funding Source: | American Brain Tumor Association |
| Role: | PI |
| Title: | Ultrasound-mediated activation of STING using a clinical scanner for the immunotherapy of cancer |
| Funding Source: | American Cancer Society |
| Role: | PI |
| Title: | Engineering mRNA encapsulated extracellular vesicles for in vivo chimeric antigen receptor macrophage therapy for glioblastoma |
| Funding Source: | NIH/NCI |
| Role: | PI |
| Title: | Engineering In Vivo Chimeric Antigen Receptor Macrophages (CARMs) using mRNA-exosomes for Cancer Immunotherapy |
| Funding Source: | NIH/NCI |
| Role: | Principal Investigator-MDACC |
| Title: | Reversing Aging Associated Resistance to Cancer Immunotherapy |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| Title: | Glioblastoma immunotherapy with dual phagocytosis checkpoint blockade |
| Funding Source: | American Cancer Society (ACS) |
| Role: | PI |
| Title: | 6-thio-deoxyguanosine: A Novel Immunogenic Telomerase-mediated Therapy in Glioblastoma |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Title: | Treating Metastatic Cancer using Microbubble-assisted Ultrasound-guided Immunotherapy of Cancer (MUSIC) |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| Title: | Ultrasound-Guided Targeted STING Activation for Breast Cancer Immunotherapy |
| Funding Source: | Department of Defense (DOD) |
| Role: | PI |
| Title: | Therapeutic targeting of multiple glioblastoma phagocytosis checkpoints using a novel bispecific antibody |
| Funding Source: | NIH/NINDS |
| Role: | PI |
| Title: | Ultrasound-guided cancer immunotherapy with targeted nanodroplets |
| Funding Source: | NIH/NCI |
| Role: | PI |
| Title: | Engineering second generation in vivo chimeric antigen receptor macrophages (CARMs) for glioblastoma therapy |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| Title: | Targeted immune activation with ultrasound (TIAUS) for cancer therapy |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| Title: | Ultrasound-guided cancer immunotherapy with targeted nanodroplets |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| Title: | Engineering in vivo chimeric antigen receptor macrophages for diffuse midline glioma |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| Title: | Engineering chimeric antigen receptor macrophages for glioblastoma immunotherapy |
| Funding Source: | American Cancer Society (ACS) |
| Role: | PI |
| Title: | A Novel Selective IL-2 Mimic for Combination Immunotherapy of Breast Cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-PI |
| Title: | Renal Cell Carcinoma Surveillance by Immuno-Lipoplex Nanoparticle Platform |
| Funding Source: | NIH/NCI |
| Role: | PI |
| Title: | Eliciting abscopal effect of combined radiotherapy, PD-1 blockade and NL-201 in localized and metastatic cancers |
| Funding Source: | Neoleukin Inc |
| Role: | PI |
| Title: | Engaging the Immune System to Improve Metastatic Breast Cancer Treatment |
| Funding Source: | Susan G. Komen Foundation |
| Role: | PI |
| Title: | Circulating Exosome-Based Biomarker for Treatment Monitoring in Anal Cancer |
| Funding Source: | Radiation Oncology Institute |
| Role: | PI |
| Title: | A Phagocytosis Modulating Nanomedicine for Targeted Breast Cancer Immunotherapy |
| Funding Source: | NIH/NCI |
| Role: | PI |
| Title: | Bridging Innate and Adaptive Glioblastoma Immunity via Phagocytosis Checkpoint Blockade |
| Funding Source: | American Brain Tumor Association |
| Role: | PI |
| Title: | CD24 as a novel therapeutic target for glioblastoma immunotherapy |
| Funding Source: | UT Southwestern Simmons Cancer Center |
| Role: | PI |
| Title: | First time, tenure track faculty recruitment award |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| Title: | UT Rising Stars Award |
| Funding Source: | University of Texas Systems |
| Role: | PI |
| Title: | High throughput multiplexed immunological profiling of glioblastoma |
| Funding Source: | ASCO/Conquer Cancer Foundation |
| Role: | PI |
| Title: | Combining chemoradiation with anti-phosphatidylserine blockade promotes immunogenic phagocytosis to generate long-lasting anti-tumor immunity |
| Funding Source: | Radiological Society of North America (RSNA) |
| Role: | PI |
Patient Reviews
CV information above last modified November 07, 2024